PLEASE NOTE - These forms were designed for optional use within Part 822-5 Chemical Dependence Opioid Treatment Programs and supports regulatory compliance. These tools support minimum OASAS operating regulations and ancillary documentation needs, as applicable; these are offered as a guide and may be modified. If you would like to customize these forms to add your program name, modify the forms for parental collaboration, or have any questions regarding the use of these forms to achieve regulatory compliance, contact the Technical Assistance/Systems Reform Unit by e-mail at: TechnicalAssistance@oasas.ny.gov.
- Non-Crisis Level of Care Determination (TA-2)
- Comprehensive Psychosocial Evaluation (TA-5)
- Communicable Disease Risk Assessment (TA-6a)
- Individual Treatment/Recovery Plan (TA-7)
- Individual Treatment/Recovery Plan Review (TA-8)
- Discharge Plan (TA-14)
- Medication Administration/Management Note (TA-17)
- Peer Support Note (TA-18)
- Screening Form (TA-20)
- Brief Intervention Note (TA-21)
- Pre-Admissions Assessment (TA-22)
- Individual Progress Note (TA-24)
- Group Progress Note (TA-25)
- Brief Treatment Note (TA-26)
- Collateral Contact Note (TA-27)
- Complex Care Coordination Note (TA-28)
- Take-Home Medication Verification (TA-29)
For assistance or concerns regarding accessibility of any of the documents on this page, contact the OASAS Communications Bureau at 518-457-8299 or via e-mail at Communications@oasas.ny.gov.